Veteran patients have been successfully dosed with take home APEX-52 microdose and in-clinic APEX-90 macrodose drug assets, in each case under multi-dose protocols addressing moderate or severe ...
Veteran to receive APEX-90 macrodose psilocybin drug product in combination with assisted psychotherapy consistent with SUMMIT-90 clinical trial protocol. "Every Veteran matters but we are often left ...
Report champions expansion of early access and funding for Canadian Veterans. VANCOUVER, BC, Nov. 17, 2023 /PRNewswire/ - Apex Labs Ltd. (APEX or the Company), a pharmaceutical company transforming ...
Authorized to sell psilocybin through Health Canada's Special Access Program. VANCOUVER, BC, Feb. 14, 2024 /PRNewswire/ - Apex Labs Ltd. (APEX or the Company), a pharmaceutical company transforming ...
Psychiatrist Dr. Mark Johnston as CMO and senior pharmaceutical commercialization expert Greg Rutherford as CCO accelerates APEX's ability to bring new drugs to market. VANCOUVER, BC, Aug. 10, 2023 ...
VANCOUVER, BC, March 7, 2024 /PRNewswire/ - Apex Labs Ltd. (APEX or the Company), a pharmaceutical company transforming the standard of mental health care with psilocybin is pleased to announce the ...
Psychiatrist Dr. Mark Johnston as CMO and senior pharmaceutical commercialization expert Greg Rutherford as CCO accelerates APEX's ability to bring new drugs to market. Dr. Johnston, APEX CMO has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results